Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro.

[1]  Aditya K. Gupta,et al.  New therapeutic options for onychomycosis , 2012, Expert opinion on pharmacotherapy.

[2]  Lusiana Lusiana.  In vitro evaluation of poloxamer 407-based formulations for topical antifungal administration of terbinafine HCl and assessment of keratin film from human hair as a nail plate model , 2012 .

[3]  Lusiana,et al.  Keratin film made of human hair as a nail plate model for studying drug permeation. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  D. Monti,et al.  Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation , 2011, The British journal of dermatology.

[5]  Lusiana,et al.  Preparation, Characterization, and In Vitro Permeation Study of Terbinafine HCl in Poloxamer 407-Based Thermogelling Formulation for Topical Application , 2011, AAPS PharmSciTech.

[6]  S. Murdan,et al.  An Assessment of the Human Nail Plate pH , 2011, Skin Pharmacology and Physiology.

[7]  I. Kaur,et al.  Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.

[8]  S. Jones,et al.  Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents , 2010, The Journal of pharmacy and pharmacology.

[9]  M. Ameen,et al.  Epidemiology of superficial fungal infections. , 2010, Clinics in dermatology.

[10]  S. Reichl.  Films based on human hair keratin as substrates for cell culture and tissue engineering. , 2009, Biomaterials.

[11]  M. Schaller,et al.  Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. , 2009, Medical mycology.

[12]  Maria R R Silva,et al.  Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods. , 2009, Revista da Sociedade Brasileira de Medicina Tropical.

[13]  M. Bashashati,et al.  COMPARISON OF THE ACTIVITIES OF FOUR ANTIFUNGAL AGENTS IN AN IN VITRO MODEL OF DERMATOPHYTE NAIL INFECTION , 2008, Indian journal of dermatology.

[14]  Maristela Pereira,et al.  cDNA representational difference analysis used in the identification of genes expressed by Trichophyton rubrum during contact with keratin. , 2007, Microbes and infection.

[15]  Daniel de Assis Santos,et al.  Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). , 2007, Journal of medical microbiology.

[16]  R. Barton,et al.  Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis. , 2006, Journal of medical microbiology.

[17]  R. Neubert,et al.  Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails. , 2006, Die Pharmazie.

[18]  D. A. Santos,et al.  Evaluation of Broth Microdilution Antifungal Susceptibility Testing Conditions for Trichophyton rubrum , 2005, Journal of Clinical Microbiology.

[19]  C. Osborne,et al.  Antifungal drug response in an in vitro model of dermatophyte nail infection. , 2004, Medical mycology.

[20]  Aditya K. Gupta,et al.  The use of topical therapies to treat onychomycosis. , 2003, Dermatologic clinics.

[21]  T. Fujii,et al.  A rapid extraction procedure of human hair proteins and identification of phosphorylated species. , 2002, Biological & pharmaceutical bulletin.

[22]  S. Murdan.  Drug delivery to the nail following topical application. , 2002, International journal of pharmaceutics.

[23]  Takao Ito,et al.  Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro , 2002, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[24]  R. J. Hay.  The future of onychomycosis therapy may involve a combination of approaches , 2001, The British journal of dermatology.

[25]  M. Ghannoum,et al.  Antifungal Susceptibility Testing of Dermatophytes: Establishing a Medium for Inducing Conidial Growth and Evaluation of Susceptibility of Clinical Isolates , 2000, Journal of Clinical Microbiology.

[26]  M. Ghannoum,et al.  Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. , 1999, Journal of the American Academy of Dermatology.